SANA
MVD-1 — nitroalkene / salicylate derivative
SANA (MVD-1 — nitroalkene / salicylate derivative) is a metabolic & fat loss research compound. Sold as a nitroalkene / salicylate derivative studied for creatine-associated thermogenesis and mitochondrial substrate handling. The creatine angle is the interesting part: creatine cycling between phosphocreatine and creatine can act as a futile cycle that burns ATP as heat rather than storing it, and that is a genuinely different fat-loss lever from appetite suppression or beta-adrenergic stimulation. Everything in that sentence comes from the vendor's own description. No published pharmacology for MVD-1 was found.
SANA quick facts
| Route | Oral |
| Frequency | 1x Daily |
| Half-life | Unknown |
| Forms | Oral |
| Evidence level | None independent — vendor description only. No PubMed entry, no trial registry record. |
50MG per capsule, 60 capsules per bottle (read from DA's rendered SPECIFICATIONS block — see vendor_specs.py), $149.99 — currently out of stock with a waiting list. The honest position: this is a compound with a mechanism story and no data behind it. Treat the thermogenesis claim as a hypothesis somebody is selling, not a finding. One credibility signal worth knowing: DA's own 'research guide' page for SANA contains no CAS number, no formula and no mechanism — just keyword strings like 'insane fat burner' and 'weight loss pill'. Every other compound in this batch has a real reference page. That tells you how new and how unsubstantiated this is.
How SANA works
Sold as a nitroalkene / salicylate derivative studied for creatine-associated thermogenesis and mitochondrial substrate handling. The creatine angle is the interesting part: creatine cycling between phosphocreatine and creatine can act as a futile cycle that burns ATP as heat rather than storing it, and that is a genuinely different fat-loss lever from appetite suppression or beta-adrenergic stimulation. Everything in that sentence comes from the vendor's own description. No published pharmacology for MVD-1 was found.
Proposed benefits
Researched for fat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
✅ Clinically validated
- None. No PubMed entry, no trial registry record, no published pharmacology for MVD-1. Everything on this page describing what it does comes from Disguised Alpha's own product listing.
📊 Correlative data
- The nearest real evidence is the creatine futile-cycle literature itself — the observation that cycling between creatine and phosphocreatine can burn ATP as heat rather than storing it. That work is about the pathway, not about this molecule, and no published link connects the two.
🧪 Theoretical / extrapolated
- Sold as a nitroalkene / salicylate derivative acting on creatine-associated thermogenesis and mitochondrial substrate handling. If that is accurate, it is a genuinely different fat-loss lever from the two the market already has — it would raise heat production rather than suppress appetite (GLP-1s) or drive beta-adrenergic output (clen).
- That 'if' is carrying the whole page. A mechanism story with no data is a hypothesis someone is selling at $149.99. DA does not publish a per-capsule strength, so there is not even a dose to reason about.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
SANA — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- Two chemistries are named in one description and each brings its own predicted problem. The salicylate arm predicts what salicylates predict: GI irritation and ulceration, bleeding risk, and tinnitus as the classic early signal of too much.
- The thermogenic arm is the one to take seriously. A compound sold for thermogenesis is a compound sold for turning substrate into heat instead of ATP. The description here is a creatine futile cycle, which would be a gentler mechanism than mitochondrial uncoupling — but nobody has demonstrated which of the two it actually does, and the failure mode of the harsher version is hyperthermia, which is the mechanism that makes DNP lethal. That is not a claim that this compound is DNP. It is the reason a thermogenic with no published pharmacology deserves more caution than one with a known mechanism, rather than less.
- If it raises heat production at all, then hot environments, hard training and dehydration all stack with it — and none of those will feel like the compound while they are happening.
What has actually been reported
- Nothing. No PubMed entry, no trial registry record, no published pharmacology for MVD-1 in any form.
- One credibility signal is worth stating plainly: the vendor's own reference page for this compound carries no CAS number, no formula and no mechanism — only marketing strings. Every other compound in this batch has a real reference page. This is the weakest evidence position of any card in the Vault and this section should be read that way.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- With no literature to compare a reaction against, your own baseline and a single variable are the only instruments you have. Change nothing else at the same time — that advice is generic everywhere else on this site and specific here.
- Stop for tinnitus, ringing, or new GI pain. Those are the salicylate signals and they arrive before the serious version does.
- Do not run it in heat, dehydrated, or alongside another thermogenic. If your resting heart rate or temperature is measurably up, that is the mechanism reporting in rather than a coincidence — and it is a reason to stop rather than to push.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- A full blood count and a metabolic panel, with liver enzymes — a baseline before, so that anything measured later has something to be compared against. With no literature to consult, your own before-and-after is the only comparison available.
Don't run this if
- You take an anticoagulant or antiplatelet, or have any history of GI ulcer or bleeding — the salicylate arm.
- Aspirin sensitivity, or asthma with nasal polyps, which is the salicylate-sensitive phenotype.
- Children and teenagers — salicylates and Reye's syndrome.
- You have surgery scheduled.
- You train in heat, or you cannot reliably distinguish overheating from working hard. Those are the conditions under which the predicted failure mode is least likely to be noticed in time.
The honest unknown
- Whether the compound does what the description says at all. Not the dose, not the duration — the mechanism itself is unverified, and every line above is conditional on a story the seller is telling.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get SANA
Buy SANA at Disguised Alpha →SANA — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What SANA moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- TSH (Thyroid-Stimulating Hormone) — ↓ expected to fall
Exogenous thyroid hormone or a thyromimetic suppresses TSH by feedback. A suppressed TSH here is the expected consequence, not evidence of thyroid disease.
What to do: TSH alone is uninterpretable on these. Run free T3 and free T4 with it or the panel means nothing. - Free T3 (Triiodothyronine) — ↑ expected to rise
Rises with dosing, and this is the number driving both the benefit and the risk.
What to do: The gap between 'metabolically effective' and 'losing muscle and beating up your heart' is narrow. Test, don't estimate. - Complete Blood Count (CBC) with Differential — ◆ worth watching
Not the marker itself — but resting heart rate and blood pressure are the real-time readouts of over-dosing here, and they move before any lab does.
What to do: Take a resting heart rate every morning. It is a better early signal than a quarterly panel. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Uncouplers and strong thermogenics raise metabolic demand and can stress liver enzymes.
What to do: Baseline liver function before, and again at 8 weeks.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for SANA — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →- Dose range and how to work up to it
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
Get the complete breakdown for SANA — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside SANA
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| HbA1c (Hemoglobin A1c) | Where you started, so you can prove the change was real |
| Fasting Insulin | Moves years before HbA1c does — the earliest signal you get |
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | Rapid fat loss shifts triglycerides fast, in both directions |
| Comprehensive Metabolic Panel (CMP) | Liver, kidney and electrolytes while intake is restricted |
The Metabolic Health & Prediabetes panel covers these in one order — 8 markers, $81.45 with the discount applied.
Check results you already have → · All 102 markers A–Z
SANA — frequently asked questions
What is SANA?
SANA (MVD-1 — nitroalkene / salicylate derivative) is a metabolic & fat loss research compound. Sold as a nitroalkene / salicylate derivative studied for creatine-associated thermogenesis and mitochondrial substrate handling. The creatine angle is the interesting part: creatine cycling between phosphocreatine and creatine can act as a futile cycle that burns ATP as heat rather than storing it, and that is a genuinely different fat-loss lever from appetite suppression or beta-adrenergic stimulation. Everything in that sentence comes from the vendor's own description. No published pharmacology for MVD-1 was found.
Where can I find SANA dosing and protocols?
Dosing, the reconstitution calculator and Coach Cam's full SANA protocol are available to members inside the Academy. This public page covers what SANA is, how it works and the evidence.
What is the half-life of SANA?
SANA has an approximate half-life of Unknown, which is part of what determines how often it's dosed.
What's the evidence behind SANA?
Current evidence level: None independent — vendor description only. No PubMed entry, no trial registry record.. SANA is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact SANA protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →